EANS-News: LifeWatch AG gibt die Resultate für das dritte Quartal 2009 am Donnerstag, den 5. November 2009 bekannt
Neuhausen am Rheinfall (euro adhoc) -
- Pressemitteilung um 07.00 Uhr MEZ - Analysten- und Medienkonferenz in Zürich um 09.30 Uhr MEZ
Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der Emittent/Meldungsgeber verantwortlich.
Quartalsbericht/Einladung Analystenkonferenz
Utl.: - Pressemitteilung um 07.00 Uhr MEZ - Analysten- und Medienkonferenz in Zürich um 09.30 Uhr MEZ
LifeWatch AG (SIX Swiss Exchange: LIFE) gibt am Donnerstag, 5. November 2009, die Resultate für das dritte Quartal 2009 bekannt.
Eine PDF-Version dieser Einladung und ein Teilnahmetalon können unter den nachfolgenden Links heruntergeladen werden:
http://www.newsaktuell.ch/pdf/lifewatch_invite_q3_german_newsaktuell.pdf
http://www.newsaktuell.ch/pdf/antworttalon.pdf
Pressemitteilung um 07.00 Uhr MEZ
LifeWatch wird international um 07.00 Uhr die Ergebnisse des dritten Quartals 2009 in einer Pressemitteilung veröffentlichen.
Analysten- und Medienkonferenz um 09.30 Uhr MEZ
Die Resultate des dritten Quartals 2009 wird LifeWatch an einer englischsprachigen Analysten- und Medienkonferenz im Detail vorstellen und analysieren am:
Donnerstag, den 5. November 2009 um 09.30 Uhr MEZ,
im Zunfthaus zur Saffran, Limmatquai 54, 8001 Zürich/SchweizBitte bestätigen Sie Ihre Teilnahme durch Rücksenden des beigefügten
Anmeldeformulars bis zum 3. November 2009.
Zu LifeWatch AG
LifeWatch AG, mit Hauptsitz in Neuhausen am Rheinfall und Kotierung an der SIX Swiss Exchange (LIFE) in der Schweiz, ist der führende Anbieter von modernen Telemedizinsystemen und Überwachungsdienstleis-tungen (Monitoring Services) für Personengruppen, die von Hochrisikopatienten und chronisch Kranken bis zu normalen Konsumenten von Gesundheits- und Wellnessprodukten reichen. LifeWatch verfügt über Niederlassungen in den USA, den Niederlanden, Japan, Grossbritannien, der Schweiz und in Israel. In den USA ist LifeWatch AG durch die neu gegründete Holding-Gesellschaft LifeWatch, Corp., die ihrerseits LifeWatch Services, Inc. (ein Unternehmen für Überwachungsdienstleistungen insbesondere bei Herzerkrankungen - Cardiac Monitoring Services) und LifeWatch Technologies, Inc. (ein Hersteller von Telekardiologie-Produkten) besitzt, vertreten. www.lifewatch.com
E-mail alerts: Um regelmässig die neusten Informationen zu LifeWatch zu erhalten, tragen Sie sich bitte in die Verteilerliste ein unter http://production.investis.com/lifewatch/alert-service/
This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, business strategy and plans and objectives for future operations, are forward- looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward- looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short term and long term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward- looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.
Rückfragehinweis:
Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG
Tel +41 52 632 00 50 | Fax +41 52 632 00 51 | Email kobibe@lifewatch.com
Sensus Investor & Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch
Branche: Gesundheitsdienste
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market (Freiverkehr) / XETRA
SIX Swiss Exchange / Hauptsegment
Berlin / Freiverkehr